Julian Krappinger

Mr. Julian Krappinger

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Jelena KrsticJelena Krstic
Jelena Krstic
ADAlexander Deutsch
Alexander Deutsch
JFJulia Fuchs
Julia Fuchs
Martin GausterMartin Gauster
Martin Gauster
TSTina Gorsek Sparovec
Tina Gorsek Sparovec
Berthold HuppertzBerthold Huppertz
Berthold Huppertz
Placenta-specific trophoblast and tumor cells exhibit many common characteristics. Trophoblast cells invade maternal tissues while being tolerated by the maternal immune system. Similarly, tumor cells can invade surrounding tissues and escape the immune system. Importantly, both trophoblast and tumor cells are supported by an abetting microenvironment, which influences invasion, angiogenesis, and immune tolerance/evasion, among others. However, in contrast to tumor cells, the metabolic, proliferative, migrative, and invasive states of trophoblast cells are under tight regulatory control. In this review, we provide an overview of similarities and dissimilarities in regulatory processes that drive trophoblast and tumor cell fate, particularly focusing on the role of the abetting microenvironments.

1 November 2021 in Journal of Biotechnology
Verified
Journal Article
Open access
JKJulian Krappinger
Julian Krappinger
LBLilli Bonstingl
Lilli Bonstingl
KPKatrin Pansy
Katrin Pansy
KSKatja Sallinger
Katja Sallinger
NWNick I. Wreglesworth
Nick I. Wreglesworth
JFJulia Feichtinger
Julia Feichtinger
Non-coding natural antisense transcripts (ncNATs) are regulatory RNA molecules that are overlapping with as well as complementary to other transcripts. These transcripts are implicated in a broad variety of biological and pathological processes, including tumorigenesis and oncogenic progression. With this complex field still in its infancy, annotations, expression profiling and functional characterisations of ncNATs are far less comprehensive than those for protein-coding genes, pointing out substantial gaps in the analysis and characterisation of these regulatory transcripts. In this review, we discuss ncNATs from an analysis perspective, in particular regarding the use of high-throughput sequencing strategies, such as RNA-sequencing, and summarize the unique challenges of investigating the antisense transcriptome. Finally, we elaborate on their potential as biomarkers and future targets for treatment, focusing on cancer.